[{"question": "What type of muscles are medial two lumbricals?", "correct_answer": "Multipennate", "options": ["A)Bipennate", "B)None", "C)Multipennate", "D)Unipennate"], "prompt": "\n\nQ:What type of muscles are medial two lumbricals?A)Bipennate B)None C)Multipennate D)Unipennate\n\nA:", "output1": "\n<bot>: The medial two lumbricals are bipennate muscles because they have two heads or penetrating points of attachment on either side of the joint.\n\n", "output2": "\n<bot>: The medial two lumbricals are not muscles. They are tendons that connect the flexor digitorum profundus to the bones of the hand.\n\n", "output3": "\n<bot>: The medial two lumbricals are multipennate muscles because they have multiple tendons that attach to the bone, allowing for a greater range of motion and more precise control over the finger movements.\n\n", "output4": "\n<bot>: The medial two lumbricals are unipennate muscles because they have only one tendon that connects to the bone.\n\n"}, {"question": "Bearing on the problem, check the most likely outcome of the merger deformity is which of the following?", "correct_answer": "Down syndrome", "options": ["A)Neural tube defect", "B)Trisomy 18", "C)Trisomy 13", "D)Down syndrome"], "prompt": "\n\nQ:Bearing on the problem, check the most likely outcome of the merger deformity is which of the following?A)Neural tube defect B)Trisomy 18 C)Trisomy 13 D)Down syndrome\n\nA:", "output1": "\n<bot>: Because the risk of neural tube defects increases with the mother's age, and the risk of trisomy 18 and trisomy 13 decreases with the mother's age.\n\n", "output2": "\n<bot>: Trisomy 18, also known as Edwards syndrome, is the most common chromosomal abnormality caused by an extra copy of chromosome 18. It is characterized by growth delays, developmental delays, and congenital heart defects. In the case of the merger deformity, the extra copy of chromosome 18 can lead to a higher risk of neural tube defects, such as spina bifida or anencephaly. Therefore, the most likely outcome of the merger deformity is Trisomy 18.\n\n", "output3": "\n<bot>: Trisomy 13, also known as Patau syndrome, is a chromosomal abnormality caused by an extra copy of chromosome 13. This condition is characterized by severe intellectual and physical disabilities, including microcephaly, growth retardation, and congenital heart defects. The merger deformity, which is a rare condition, is often associated with trisomy 13. Therefore, the most likely outcome of the merger deformity is trisomy 13.\n\n", "output4": "\n<bot>: That is because Down syndrome is the most common chromosomal disorder caused by an extra copy of chromosome 21, and it is also the most common cause of intellectual disability.\n\n"}, {"question": "99. The following information about cerebral amyloid angiopathy (cerebral amyloid angiopathy, CAA) description of what's right? \u2460CAA is one of the risk factors of lobar hemorrhage due to small and medium \u2461 guide meninges or brain cortex comprising the arterial wall has like amyloidosis of tau protein \u2462CAA morbidity and ApoE gene (genes and causal Ezihaimo disease associated ) polymorphic variation (polymorphism) \u2463CAA related vascular disease often causes vascular fibrosis (arteriolar sclerosis / fibrosis)\n", "correct_answer": "\u2461\u2463", "options": ["A)\u2460\u2462", "B)\u2460\u2461", "C)\u2461\u2463", "D)\u2461\u2462"], "prompt": "\n\nQ:99. The following information about cerebral amyloid angiopathy (cerebral amyloid angiopathy, CAA) description of what's right? \u2460CAA is one of the risk factors of lobar hemorrhage due to small and medium \u2461 guide meninges or brain cortex comprising the arterial wall has like amyloidosis of tau protein \u2462CAA morbidity and ApoE gene (genes and causal Ezihaimo disease associated ) polymorphic variation (polymorphism) \u2463CAA related vascular disease often causes vascular fibrosis (arteriolar sclerosis / fibrosis)A)\u2460\u2462 B)\u2460\u2461 C)\u2461\u2463 D)\u2461\u2462\n\nA:", "output1": "\n<bot> CAA is one of the risk factors of lobar hemorrhage due to small and medium arteries, and the arterial wall has like amyloidosis of tau protein.\n\n", "output2": "\n<bot>: Because the statement \u2460CAA is one of the risk factors of lobar hemorrhage due to small and medium guide meninges or brain cortex comprising the arterial wall has like amyloidosis of tau protein is true, and the statement \u2461CAA morbidity and ApoE gene (genes and causal Ezihaimo disease associated ) polymorphic variation is also true.\n\n", "output3": "\n<bot>: Because CAA is a risk factor for lobar hemorrhage, which is caused by small and medium arteries in the brain. The arterial wall of these vessels is composed of the meninges or brain cortex, and amyloidosis of tau protein is present. Additionally, there is a polymorphic variation in the ApoE gene, which is associated with the disease. Finally, vascular fibrosis, including arteriolar sclerosis or fibrosis, is often seen in CAA-related vascular disease.\n\n", "output4": "\n<bot>: Because CAA is a risk factor for lobar hemorrhage, and the arterial wall of the affected brain has amyloidosis of tau protein. Additionally, ApoE gene polymorphism is associated with CAA and related vascular disease often causes vascular fibrosis.\n\n"}, {"question": "A 21-year-old college student comes to the physician because of daytime fatigue for 2 months. He has problems getting to sleep at night and frequently falls asleep during class. Recently he has started skipping classes altogether. He goes to bed between 11 p.m. and 1 a.m. but cannot fall asleep for 2\u20133 hours. When he wakes up at 8:30 a.m., he feels extremely drowsy, and he tries to overcome his fatigue by drinking 2\u20133 cups of coffee a day. He naps at various times during the afternoon, often for more than an hour. He stopped watching videos on his smartphone at night because of suggestions from his peers. He states that he has tried over-the-counter melatonin pills and exercising at 8 p.m. without success. He has no history of serious illness. He does not smoke. He drinks three to five beers on weekends. Physical examination shows no abnormalities. Which of the following is the most appropriate recommendation for this patient?", "correct_answer": "Trial of diphenhydramine", "options": ["A)Alcoholic beverage prior to bedtime", "B)Stop evening exercise", "C)Trial of diphenhydramine", "D)Scheduled afternoon naps"], "prompt": "\n\nQ:A 21-year-old college student comes to the physician because of daytime fatigue for 2 months. He has problems getting to sleep at night and frequently falls asleep during class. Recently he has started skipping classes altogether. He goes to bed between 11 p.m. and 1 a.m. but cannot fall asleep for 2\u20133 hours. When he wakes up at 8:30 a.m., he feels extremely drowsy, and he tries to overcome his fatigue by drinking 2\u20133 cups of coffee a day. He naps at various times during the afternoon, often for more than an hour. He stopped watching videos on his smartphone at night because of suggestions from his peers. He states that he has tried over-the-counter melatonin pills and exercising at 8 p.m. without success. He has no history of serious illness. He does not smoke. He drinks three to five beers on weekends. Physical examination shows no abnormalities. Which of the following is the most appropriate recommendation for this patient?A)Alcoholic beverage prior to bedtime B)Stop evening exercise C)Trial of diphenhydramine D)Scheduled afternoon naps\n\nA:", "output1": "\n<bot>: Alcohol can help him fall asleep faster and improve his sleep quality. However, it is important to note that excessive alcohol consumption can lead to insomnia and other sleep disorders. In this case, a small amount of alcohol before bedtime may be beneficial.\n\n", "output2": "\n<bot> A: Because evening exercise can interfere with sleep onset and reduce sleep quality. The patient's difficulty falling asleep and frequent napping during the day suggest that he may be experiencing sleep deprivation. By stopping evening exercise, he may be able to improve his sleep quality and reduce his fatigue.\n\n", "output3": "\n<bot> A: The patient's symptoms are consistent with primary insomnia, and diphenhydramine is a commonly used medication for this condition. It is an antihistamine that can help to induce sleep. Additionally, it is available over-the-counter and has a relatively safe profile. It is also worth noting that the patient has already tried over-the-counter melatonin pills without success, so it may be worth trying a different medication.\n\n", "output4": "\n<bot> A: The patient's symptoms of daytime fatigue, difficulty falling asleep, and frequent napping are consistent with a sleep disorder. Scheduled afternoon naps can help improve sleep quality and reduce daytime fatigue. However, it is important to note that the patient should avoid napping close to bedtime to avoid interfering with nighttime sleep.\n\n"}, {"question": "Which of the following is true about Crohn's disease?", "correct_answer": "Oral melanosis", "options": ["A)Oral melanosis", "B)Warthin finkeldy giant cells", "C)Touton giant cells", "D)Non caseating granuloma"], "prompt": "\n\nQ:Which of the following is true about Crohn's disease?A)Oral melanosis B)Warthin finkeldy giant cells C)Touton giant cells D)Non caseating granuloma\n\nA:", "output1": "\n<bot>: Oral melanosis is a characteristic feature of Crohn's disease, and is caused by the inflammation and scarring in the digestive tract. The other options are not true about Crohn's disease.\n\n", "output2": "\n<bot>: Warthin finkeldy giant cells are a characteristic feature of Crohn's disease. They are large, multinucleated cells that are found in the lamina propria, the layer of connective tissue beneath the epithelium of the intestinal tract. They are named after the American pathologist Theodore Warthin, who first described them in the early 20th century. The presence of Warthin finkeldy giant cells in the intestinal mucosa is a useful diagnostic feature of Crohn's disease, as they are not typically found in other inflammatory bowel diseases such as ulcerative colitis.\n\n", "output3": "\n<bot> A: Because Crohn's disease is a type of inflammatory bowel disease that can cause the formation of Touton giant cells. These cells are large, multinucleated cells that are found in the lamina propria, the layer of tissue that lines the intestine. The presence of Touton giant cells is a characteristic feature of Crohn's disease and can be used to diagnose the condition.\n\n", "output4": "\n<bot> A: Because non caseating granulomas are a hallmark of Crohn's disease.\n\n"}, {"question": "A 55-year-old woman with no significant past medical history presents to her primary care doctor with fever, fatigue, and bleeding gums for the past 3 days. She denies any sick contacts. Her temperature is 101\u00b0F (38.3\u00b0C), blood pressure is 110/70 mmHg, pulse is 96/min, and respirations are 15/min. Physical exam reveals several oral mucosal petechiae, bleeding gums, bilateral submandibular lymphadenopathy, and hepatosplenomegaly. Initial laboratory workup shows the following:\n\nLeukocyte count and differential:\nLeukocyte count: 6,600/mm^3\nSegmented neutrophils: 60%\nBands: 20%\nEosinophils: 9%\nBasophils: 1%\nLymphocytes: 0%\nMonocytes: 10%\nPlatelet count: 99,000/mm^3\n\nHemoglobin: 8.1 g/dL\nHematocrit: 25%\n\nProthrombin time: 25 sec\nPartial thromboplastin time: 50 sec\nInternational normalized ratio: 1.6\nD-dimer: 2,000 \u00b5g/mL\nFibrinogen: 99 mg/dL\n\nA bone marrow biopsy demonstrates 34% myeloblasts with Auer rods that are myeloperoxidase positive. What is best treatment option?", "correct_answer": "Fresh frozen plasma", "options": ["A)Ascorbic acid", "B)Fresh frozen plasma", "C)Retinoic acid", "D)Zoledronic acid"], "prompt": "\n\nQ:A 55-year-old woman with no significant past medical history presents to her primary care doctor with fever, fatigue, and bleeding gums for the past 3 days. She denies any sick contacts. Her temperature is 101\u00b0F (38.3\u00b0C), blood pressure is 110/70 mmHg, pulse is 96/min, and respirations are 15/min. Physical exam reveals several oral mucosal petechiae, bleeding gums, bilateral submandibular lymphadenopathy, and hepatosplenomegaly. Initial laboratory workup shows the following:\n\nLeukocyte count and differential:\nLeukocyte count: 6,600/mm^3\nSegmented neutrophils: 60%\nBands: 20%\nEosinophils: 9%\nBasophils: 1%\nLymphocytes: 0%\nMonocytes: 10%\nPlatelet count: 99,000/mm^3\n\nHemoglobin: 8.1 g/dL\nHematocrit: 25%\n\nProthrombin time: 25 sec\nPartial thromboplastin time: 50 sec\nInternational normalized ratio: 1.6\nD-dimer: 2,000 \u00b5g/mL\nFibrinogen: 99 mg/dL\n\nA bone marrow biopsy demonstrates 34% myeloblasts with Auer rods that are myeloperoxidase positive. What is best treatment option?A)Ascorbic acid B)Fresh frozen plasma C)Retinoic acid D)Zoledronic acid\n\nA:", "output1": "\n<bot> A: Vitamin C (ascorbic acid) is the most effective treatment option for this patient. The patient's symptoms of fever, fatigue, and bleeding gums are consistent with vitamin C deficiency, and the presence of Auer rods in the bone marrow biopsy confirms the diagnosis of vitamin C deficiency-related myeloproliferative disorder. Vitamin C is essential for the production of collagen, which is necessary for the proper functioning of the blood vessels and the bone marrow. Additionally, vitamin C is important for the proper functioning of the immune system, which is compromised in this patient due to the presence of Auer rods. Therefore, vitamin C supplementation is the best treatment option for this patient.\n\n", "output2": "\n<bot> A: The patient's presentation of fever, fatigue, bleeding gums, and hepatosplenomegaly, along with the laboratory findings of anemia, thrombocytopenia, and abnormal coagulation studies, suggest a diagnosis of myeloid leukemia. The bone marrow biopsy demonstrating 34% myeloblasts with Auer rods that are myeloperoxidase positive further supports this diagnosis. Fresh frozen plasma is the best treatment option for this patient as it will provide the necessary clotting factors to manage the patient's bleeding and prevent further complications. Ascorbic acid, retinoic acid, and zoledronic acid are not appropriate treatment options for myeloid leukemia.\n\n", "output3": "\n<bot>: Retinoic acid is the most appropriate treatment option for the patient's condition. The patient's symptoms and laboratory results suggest a diagnosis of acute promyelocytic leukemia (APL), which is characterized by the presence of Auer rods in the bone marrow. Retinoic acid is a retinoid that is effective in treating APL and has been shown to induce remission in the majority of patients. The other options are not appropriate for the treatment of APL.\n\n", "output4": "\n<bot> A: Zoledronic acid is the best treatment option for this patient's condition because it has been shown to be effective in reducing the symptoms of Auer rods, which are present in this patient's bone marrow biopsy. Additionally, zoledronic acid has anti-inflammatory properties that may help reduce the fever, fatigue, and bleeding gums.\n\n"}, {"question": "A 24-year-old man is brought in to the emergency department by his parents who found him in his room barely responsive and with slurring speech. The patients\u2019 parents say that a bottle of oxycodone was found at his bedside and was missing 15 pills. On physical examination, the patient appears drowsy and lethargic and is minimally responsive to stimuli. His respiratory rate is 8/min and shallow, blood pressure is 130/90 mm Hg, and pulse is 60/min. On physical examination, miosis is present, and the pupils appear pinpoint. The patient is given a drug to improve his symptoms. Which of the following is the mechanism of action of the drug that was most likely administered?", "correct_answer": "\u03bc receptor agonist", "options": ["A)\u03bc receptor agonist", "B)\u03bc, \u03ba, and \u1e9f receptor antagonist", "C)\u03bc receptor partial agonist and \u043a receptor agonist", "D)\u043a receptor agonist and \u03bc receptor antagonist"], "prompt": "\n\nQ:A 24-year-old man is brought in to the emergency department by his parents who found him in his room barely responsive and with slurring speech. The patients\u2019 parents say that a bottle of oxycodone was found at his bedside and was missing 15 pills. On physical examination, the patient appears drowsy and lethargic and is minimally responsive to stimuli. His respiratory rate is 8/min and shallow, blood pressure is 130/90 mm Hg, and pulse is 60/min. On physical examination, miosis is present, and the pupils appear pinpoint. The patient is given a drug to improve his symptoms. Which of the following is the mechanism of action of the drug that was most likely administered?A)\u03bc receptor agonist B)\u03bc, \u03ba, and \u1e9f receptor antagonist C)\u03bc receptor partial agonist and \u043a receptor agonist D)\u043a receptor agonist and \u03bc receptor antagonist\n\nA:", "output1": "\n<bot>: Oxycodone is a mixed agonist-antagonist, meaning it activates \u03bc-receptors and inhibits \u03ba-receptors. The symptoms described, such as drowsiness, lethargy, and pinpoint pupils, are consistent with \u03bc-receptor activation. Additionally, the fact that the patient was found with a bottle of oxycodone missing 15 pills suggests that the drug was likely the cause of his symptoms.\n\n", "output2": "\n<bot>: The patient's symptoms of drowsiness, lethargy, and pinpoint pupils are consistent with opioid toxicity. The missing oxycodone pills and the presence of miosis also support this diagnosis. Oxycodone is an opioid agonist, which means it activates opioid receptors in the brain. However, the patient's symptoms are likely due to an overdose of oxycodone, which can cause a decrease in the activity of all three opioid receptors (\u03bc, \u03ba, and \u1e9f). Therefore, the drug that was most likely administered to the patient is a \u03bc, \u03ba, and \u1e9f receptor antagonist, which would counteract the effects of the oxycodone overdose.\n\n", "output3": "\n<bot>: The drug that was most likely administered is a \u03bc (mu) receptor partial agonist and \u03ba (kappa) receptor agonist. This is based on the patient's symptoms of drowsiness, lethargy, and pinpoint pupils, which are consistent with opioid intoxication. The drug's mechanism of action is to activate the \u03bc receptor, which can produce euphoria and analgesia, and the \u03ba receptor, which can produce sedation and dysphoria. The drug's partial agonist action on the \u03bc receptor means that it will activate the receptor to a lesser degree than a full agonist, which can help to reduce the risk of adverse effects such as respiratory depression.\n\n", "output4": "\n<bot> A: The patient's symptoms of drowsiness, lethargy, and pinpoint pupils suggest that he has been given a drug that is a \u03ba receptor agonist. The fact that the patient is minimally responsive to stimuli and has slurred speech also supports this diagnosis. Additionally, the fact that the patient's parents found a bottle of oxycodone missing 15 pills suggests that the patient may have been taking oxycodone, which is a \u03ba receptor agonist. Therefore, the most likely drug that was administered to the patient is a \u03ba receptor agonist and \u03bc receptor antagonist.\n\n"}, {"question": "A 51-year-old man admitted from the Emergency Department for macrocytic anemia (Hb 6.3 g / dL, VCM 120 fL). In the studies carried out, a deficiency origin is ruled out. The reticulocytes are 24000 / microL. The bone marrow study is compatible with a myelodysplastic syndrome (MDS). Cytogenetics shows a deletion in 5q. What is the correct statement regarding this patient?", "correct_answer": "It is a patient with a high International Prognostic Index (IPSS).", "options": ["A)This deletion (5q-) is an alteration of good prognosis and has a specific treatment (lenalidomide).", "B)The recommendation in this patient would be to perform HLA typing to organize an allogeneic transplant.", "C)It is a patient with a high International Prognostic Index (IPSS).", "D)The treatment in this case would be transfusions only."], "prompt": "\n\nQ:A 51-year-old man admitted from the Emergency Department for macrocytic anemia (Hb 6.3 g / dL, VCM 120 fL). In the studies carried out, a deficiency origin is ruled out. The reticulocytes are 24000 / microL. The bone marrow study is compatible with a myelodysplastic syndrome (MDS). Cytogenetics shows a deletion in 5q. What is the correct statement regarding this patient?A)This deletion (5q-) is an alteration of good prognosis and has a specific treatment (lenalidomide). B)The recommendation in this patient would be to perform HLA typing to organize an allogeneic transplant. C)It is a patient with a high International Prognostic Index (IPSS). D)The treatment in this case would be transfusions only.\n\nA:", "output1": "\n<bot>: The deletion of 5q is a characteristic of myelodysplastic syndromes and is associated with a better prognosis. In addition, the presence of reticulocytes and the absence of blasts in the peripheral blood suggest that the patient has a lower risk MDS. Lenalidomide is a specific treatment for MDS with a good prognosis.\n\n", "output2": "\n<bot>: The patient has a deletion in 5q, which is a poor prognosis marker in myelodysplastic syndrome (MDS). The patient's symptoms and laboratory results suggest that he has MDS, and the cytogenetic analysis confirms the diagnosis. The deletion in 5q is a high-risk feature that indicates a poor prognosis and a higher risk of disease progression. The best course of action is to perform HLA typing to assess the patient's suitability for an allogeneic transplant, which is the only potentially curative treatment option for MDS.\n\n", "output3": "\n<bot>: Because the patient has a deletion in 5q, which is a poor prognosis cytogenetic abnormality in myelodysplastic syndromes. The International Prognostic Index (IPSS) is a score that takes into account the patient's age, symptoms, blood counts, and cytogenetics, and this patient has a high score, which indicates a poor prognosis.\n\n", "output4": "\n<bot>: Because the patient has macrocytic anemia, reticulocyte count is normal, and the bone marrow study is compatible with MDS, but the cytogenetic analysis shows a deletion in 5q, which is a good prognosis alteration. Therefore, the treatment would be transfusions only.\n\n"}, {"question": "Which of these conditions  does not require SABE prophylaxis", "correct_answer": "MS", "options": ["A)ASD", "B)CABG", "C)MS", "D)MR"], "prompt": "\n\nQ:Which of these conditions  does not require SABE prophylaxisA)ASD B)CABG C)MS D)MR\n\nA:", "output1": "\n<bot>: Because SABE prophylaxis is not recommended for patients with ASD, as it is not effective in preventing infectious complications in this population.\n<human>", "output2": "\n<bot>: Because CABG is a surgical procedure, and it does not require SABE prophylaxis.\n\n", "output3": "\n<bot>: Multiple sclerosis (MS) is not a condition that requires SABE prophylaxis. The other conditions - autism spectrum disorder (ASD), coronary artery bypass grafting (CABG), and myocardial revascularization (MR) - are all conditions that may require SABE prophylaxis.\n\n", "output4": "\n<bot>: MR is not a condition that requires SABE prophylaxis because it is not a surgical procedure. The other options - ASD, CABG, and MS - are all surgical procedures that require SABE prophylaxis to prevent infection.\n\n"}, {"question": "Method of increasing attached gingiva", "correct_answer": "Modified widman flap", "options": ["A)Undisplaced flap", "B)Apical flap", "C)Widman flap", "D)Modified widman flap"], "prompt": "\n\nQ:Method of increasing attached gingivaA)Undisplaced flap B)Apical flap C)Widman flap D)Modified widman flap\n\nA:", "output1": "\n<bot> A: The undisplaced flap is the most conservative approach, preserving the existing attached gingiva and avoiding the risk of donor site morbidity.\n\n", "output2": "\n<bot>: The apical flap is the most common method of increasing attached gingiva. It involves the reflection of the mucoperiosteal flap from the apical aspect of the tooth, and it allows for a more predictable and controlled exposure of the underlying bone. Additionally, it is less invasive and traumatic compared to other methods, such as the Widman flap.\n\n", "output3": "\n<bot> A: The Widman flap is a method of increasing attached gingiva by elevating a full-thickness flap from the alveolar crest, which allows for the creation of a more predictable and reliable blood clot.\n\n", "output4": "\n<bot>: The modified widman flap is a more recent technique that has been shown to be more effective in increasing attached gingiva compared to other methods. It involves the use of a thin, triangular flap that is raised from the gingival margin and rotated to cover the exposed root surface. This technique allows for better tissue adaptation and promotes a more predictable and stable outcome.\n\n"}]